Skip to content

Efficacy of lidocaine intravesical administration in treating moderate to severe catheter-related bladder discomfort after surgery

Efficacy of lidocaine intravesical administration in treating moderate to severe catheter-related bladder discomfort after surgery:a prospective, randomized,double-blind, controlled study.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079597
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CRBD

Interventions

Lidocaine group: lidocaine intravesical administration
Normal saline group:Normal saline intravesical administration

Sponsors

no sponsor
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-90 years old; 2) ASAI.-II. 3) Patients with moderate to severe CRBD who suffered moderate to severe CRBD after surgery; 4) Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Refusal to participate in this study; 2) Lidocaine allergy; 3) Adams-Stokes syndrome (acute cardiogenic ischemic syndrome), pre-excitation syndrome, severe heart block (including sinus, atrioventricular and intraventricular block). 4) Severe dementia or speech impairment that prevents them from communicating; 5) Patients with neurogenic bladder disease. 6) Patients using diuretics during surgery.

Design outcomes

Primary

MeasureTime frame
urge incontinence level(urinary urgency and urinary frequency) ;

Secondary

MeasureTime frame
Pain level;Degree of agitation;

Countries

China

Contacts

Public ContactMao Xiaoyu

The Second Affiliated Hospital of Zhengzhou University

mxylove861125@163.com+86 152 9087 0372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026